Pfizer and Johnson & Johnson's Alzheimer's drug failed to help patients showing early signs of the disease, but it could get another chance as scientists test whether the devastating illness should be treated before symptoms appear
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment